Ranoux Claude Form 5 INVO Bioscience / Claude Ranoux ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

X

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Ranoux Claude

(Last) (First) (Middle)

8 CHESTNUT STREET

(Street)

WINCHESTER MA 01890

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INVO Bioscience, Inc. [ IVOB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
President

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2011

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
INVO Bioscience Common Stock (Free trading)	02/11/2011		D4	20,000	D	$0.05	25,813,867	D
INVO Bioscience Common Stock (Free trading)	02/11/2011		D4	10,000	D	$0.052	25,803,867	D
INVO Bioscience Common Stock (Free trading)	02/14/2011		D4	10,000	D	$0.052	25,793,867	D
INVO Bioscience Common Stock (Free trading)	02/18/2011		D4	10,000	D	$0.04	25,783,867	D
INVO Bioscience Common Stock (Free trading)	02/18/2011		D4	10,000	D	$0.042	25,773,867	D
INVO Bioscience Common Stock (Free trading)	03/02/2011		D4	5,000	D	$0.028	25,768,867	D
INVO Bioscience Common Stock (Free trading)	03/04/2011		D4	10,000	D	$0.028	25,758,867	D
INVO Bioscience Common Stock (Free trading)	03/07/2011		D4	7,480	D	$0.028	25,751,387	D
INVO Bioscience Common Stock (Free trading)	03/09/2011		D4	5,000	D	$0.025	25,746,387	D
INVO Bioscience Common Stock (Free trading)	03/09/2011		D4	5,000	D	$0.027	25,741,387	D
INVO Bioscience Common Stock (Free trading)	03/11/2011		D4	10,000	D	$0.027	25,731,387	D
INVO Bioscience Common Stock (Free trading)	03/14/2011		D4	1,000	D	$0.04	25,730,387	D
INVO Bioscience Common Stock (Free trading)	03/23/2011		D4	6,000	D	$0.031	25,724,387	D
INVO Bioscience Common Stock (Free trading)	03/23/2011		D4	10,000	D	$0.033	25,714,387	D
INVO Bioscience Common Stock (Free trading)	03/23/2011		D4	10,000	D	$0.035	25,704,387	D
INVO Bioscience Common Stock (Free trading)	06/02/2011		D4	10,000	D	$0.036	25,694,387	D
INVO Bioscience Common Stock (Free trading)	06/06/2011		D4	15,071	D	$0.036	25,679,316	D
INVO Bioscience Common Stock (Free trading)	06/08/2011		D4	10,000	D	$0.033	25,669,316	D
INVO Bioscience Common Stock (Free trading)	06/08/2011		D4	11,480	D	$0.034	25,657,836	D
INVO Bioscience Common Stock (Free trading)	06/09/2011		D4	20,000	D	$0.034	25,637,836	D
INVO Bioscience Common Stock (Free trading)	06/10/2011		D4	20,000	D	$0.034	25,617,836	D
INVO Bioscience Common Stock (Free trading)	06/14/2011		D4	35,400	D	$0.04	25,582,436	D
INVO Bioscience Common Stock (Free trading)	06/15/2011		D4	5,000	D	$0.04	25,577,436	D
INVO Bioscience Common Stock (Free trading)	06/15/2011		D4	10,000	D	$0.041	25,567,436	D
INVO Bioscience Common Stock (Free trading)	06/15/2011		D4	20,000	D	$0.042	25,547,436	D
INVO Bioscience Common Stock (Free trading)	06/15/2011		D4	4,100	D	$0.047	25,543,336	D
INVO Bioscience Common Stock (Free trading)	06/22/2011		D4	5,000	D	$0.035	25,538,336	D
INVO Bioscience Common Stock (Free trading)	06/22/2011		D4	5,000	D	$0.037	25,533,336	D
INVO Bioscience Common Stock (Free trading)	06/23/2011		D4	7,100	D	$0.041	25,526,236	D
INVO Bioscience Common Stock (Free trading)	06/30/2011		D4	10,000	D	$0.04	25,516,236	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

I traded my securities on the public market using my agent, Morgan Stanley Smith Barney. Morgan Stanley was my agent until 03/29/2012, until my shares of INVO Bioscience were traded on the public market pursuant to rule 144. After March 2012, INVO Bioscience was delinquent as the company did not report to the SEC. Financial difficulties did not allow INVO Bioscience to pay the financial audits. From March 2012 until the 2 first quarters of 2017, the stock of INVO Bioscience was traded on the Pink Sheet. On 09/21/2011, I sold the last free trading shares (522,394 shares) I still owned from a pool of 840,000 free trading shares acquired in 2008. I also sold 691,790 restricted shares from a pool of 1,114,290 shares already issued to my agent to be traded on the public market. On December 31,2011, I owned 25,833,867 (2010) - 691,790 - 522,394 = 24,619,683 restricted shares.

	/s/ Claude Ranoux	07/27/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.